Lu sur : https://www.ncbi.nlm.nih.gov/pubmed/30248688
[hr]
[/hr]
Traduction disponible directement en cliquant en bas à droite de ce message sur l'expression Traduire en
[hr]
[/hr]
Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis
[Article in German; Abstract available in German from the publisher]
Wenninger S1, Schoser B1.
Abstract
Acquired myasthenia gravis (MG) is an autoimmune disease that leads to fluctuating muscle weakness and fatigue, caused by circulating antibodies against different structures of the neuromuscular junction.
In most patients, antibodies against acetylcholine receptor (AChR) can be detected.
In a smaller proportion of patients with and without AChR antibodies, antibodies to muscle-specific kinase (MuSK), or related proteins such as agrin, cortactin and low-density lipoprotein receptor-related protein 4 (LRP4), are present.
With current therapy, most patients achieve a stable condition with good quality of life and normal life expectancy.
Nevertheless, 10 to 15 % of patients fail to respond ad equately to current therapies and are defined as refractory myasthenia gravis. Their clinical course is characterized by recurrent episodes of severe, acute deterioration, which sometimes appear life threatening.
This article gives an overview of the current state of myasthenic antibody diagnostics and recommended treatment of refractory myasthenia gravis.
[hr][/hr]
Sur demande de nos donateurs, nous pouvons faire l'acquisition d'un tiré-à-part de l'article intégral... Celui-ci est disponible uniquement en allemand ...
[hr][/hr]
Message d' un membre de l'équipe technique |
Pour les utilisateurs d'I-phone ci-dessous le lien vers Google Trad https://translate.google.fr/translate?h ... 2F30248688 |
Message d' un membre de l'équipe technique |
Nous utilisons des services automatiques de traduction fournis par Yandex ou Google. Soyez vigilant sur le risque de contre-sens inhérent à ce genre d'outils. |